FXR and GPBAR1 signaling in the vascular system and liver in MASLD. A recent study published by JAHA 2023 highlights a role of bile acids in liver steatohepatitis and atherosclerosis
Vascular injury linked to metabolic dysfunction-associated steatotic liver disease (MASLD) By Stefano Fiorucci, MD and others Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease Silvia Marchianò, Michele Biagioli, Martina Bordoni, Elva Morretta, Cristina Di
Post più commentati